Psyence Biomedical Ltd. (PBM) Operating Expenses (2023 - 2025)
Psyence Biomedical (PBM) posted quarterly Operating Expenses of $573339.0 for Q3 2025, up 12.49% year-over-year from $509686.0 in Q3 2024, and up 12.49% quarter-over-quarter from $509686.0 in Q3 2024.
Psyence Biomedical Ltd. (PBM) Operating Expenses (2023 - 2025) Analysis & Trends
Psyence Biomedical's Operating Expenses history runs 3 years deep, the most recent figure standing at $573339.0 for Q3 2025.
- In Q3 2025, Operating Expenses rose 12.49% year-over-year to $573339.0; the TTM figure through Mar 2026 stood at $1.1 million (up 123.29% YoY), while the FY2026 annual figure was $2.4 million, up 52.41% from the prior year.
- Operating Expenses for Q3 2025 stood at $573339.0, up from $509686.0 in the prior quarter.
- The five-year high for Operating Expenses was $573339.0 in Q3 2025, with the low at -$24662.0 in Q3 2023.
- The 3-year median for Operating Expenses is $509686.0 (2024), against an average of $352787.7.
- The sharpest annual moves came in 2024 and 2025: Operating Expenses surged 2166.69% in 2024, then grew 12.49% in 2025.
- Psyence Biomedical's Operating Expenses stood at -$24662.0 in 2023, then soared by 2166.69% to $509686.0 in 2024, then gained by 12.49% to $573339.0 in 2025.
- Business Quant data shows PBM's Operating Expenses at $573339.0 in Q3 2025, $509686.0 in Q3 2024, and -$24662.0 in Q3 2023.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 573,339.00 |
| Sep 30, 2024 | 509,686.00 |
| Sep 30, 2023 | -24,662.00 |